When is the next results date for Gujarat Themis Biosyn Ltd?
2026-05-20 23:18:42The next results date for Gujarat Themis Biosyn Ltd is scheduled for 25 May 2026....
Read More
Gujarat Themis Biosyn Ltd Shows Mildly Bullish Momentum Amid Technical Shift
2026-05-20 08:04:13Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is reflected in a range of technical indicators, including MACD, Bollinger Bands, and moving averages, signalling a cautiously optimistic outlook for investors amid mixed monthly signals.
Read MoreGujarat Themis Biosyn Gains 6.84%: 3 Key Factors Driving the Week
2026-05-09 14:06:50Key Events This Week 4 May: Downgrade to Sell rating by MarketsMOJO amid mixed fundamentals 5 May: Technical momentum shifts to mildly bearish despite price rise 6 May: Weekly charts show mildly bullish momentum with mixed signals 8 May: Week closes at Rs.398.45, up 6.84% from open Week OpenRs.372.95 Week Close<div cl...
Read More
Gujarat Themis Biosyn Ltd Upgraded to Hold on Technical and Quality Improvements
2026-04-30 08:12:14Gujarat Themis Biosyn Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality. The upgrade, effective from 29 April 2026, follows a period of mixed performance but notable resilience in a challenging pharmaceuticals sector environment.
Read More
Gujarat Themis Biosyn Ltd Shows Mildly Bullish Momentum Amid Technical Shifts
2026-04-30 08:02:53Gujarat Themis Biosyn Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This transition is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector.
Read More
Gujarat Themis Biosyn Ltd Sees Mixed Technical Signals Amid Price Momentum Shift
2026-04-29 08:03:04Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a robust day gain of 3.97%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, warranting a nuanced analysis for investors.
Read More
Gujarat Themis Biosyn Ltd Surges 9.74% to Day's High of Rs 360.75 — Outperforms Sector by 10.65 Percentage Points
2026-04-24 10:45:58The Sensex declined by 1.07% on 24 Apr 2026, while Gujarat Themis Biosyn Ltd surged 9.74%, outperforming its Pharmaceuticals & Biotechnology sector by 10.65 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market environment.
Read More
Gujarat Themis Biosyn Ltd is Rated Sell
2026-04-20 10:10:03Gujarat Themis Biosyn Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Gujarat Themis Biosyn Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-04-17 08:03:14Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across multiple timeframes. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical indicators suggest a cautious outlook for investors navigating this evolving landscape.
Read MoreBoard Meeting Intimation for Inter Alia To Evaluate Proposal For Raising Funds Through Issue Of Equity Shares / Securities Including Compulsory Convertible Debentures Optionally Convertible Debentures And Non-Convertible Debentures..
16-Jun-2026 | Source : BSEGujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/06/2026 inter alia to consider and approve the proposal for raising funds through issue of equity shares / securities including Compulsory Convertible Debentures Optionally Convertible Debentures and Non-Convertible Debentures through preferential issue on a private placement basis or any other manner in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 and the Companies Act 2013 subject to necessary approvals including approval of the shareholders of the Company and stock exchanges as may be necessary / applicable.
Announcement under Regulation 30 (LODR)-Newspaper Publication
09-Jun-2026 | Source : BSENewspaper Publication of Postal Ballot Notice dated 6th June 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On 6Th June 2026
06-Jun-2026 | Source : BSEPlease refer to the attachment.
Corporate Actions
No Upcoming Board Meetings
Gujarat Themis Biosyn Ltd has declared 67% dividend, ex-date: 04 Sep 25
Gujarat Themis Biosyn Ltd has announced 1:5 stock split, ex-date: 10 Oct 23
Gujarat Themis Biosyn Ltd has announced 1:2 bonus issue, ex-date: 09 Aug 24
No Rights history available